Eisai Co., Ltd. and Nichi-Iko Pharmaceutical announced today that they have entered into a strategic alliance agreement ...
Nagoya City University, Chubu University, Daiichi Sankyo Company ltd. and Mitsubishi UFJ Capital Co. Ltd. announced that...
Carna Biosciences, Inc. and Sumitomo Dainippon Pharma Co., Ltd. have signed an agreement on joint research with the aim ...
Pfizer and Astellas Pharma announced that a supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) has been ...
The Government of Japan has donated $ 1.5 million to provide emergency services to vulnerable populations in conflict-af...
Sri Lanka has signed a Rs. 15 billion loan agreement with Japan to improve Sri Lanka's health and medical services. This...
PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for he...
AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced the appointme...
Tokyo based Eisai Co., Ltd. and Merck, known as MSD outside the United States and Canada, have agreed upon a strategic c...
As per reports from a Japanese news portal, the country’s health ministry said that the government-set price of bl...
Constant Pharmaceuticals LLC, a privately held US based biopharmaceutical company focused on the treatment of stroke rec...
Japanese pharma giant Takeda has announced plans to invest €25 million in the construction of a new facility at&nbs...
Singapore – Takeda Pharmaceuticals has announced the establishment of the centre of Excellence in Singapore for va...
Roche and Takeda have announced that they will be using organ-chip technology in their R&D Programs through partners...
Valeant Pharmaceuticals International’s subsidiary has entered into an exclusive license agreement with Kaken Phar...
Japan's pioneer genetic testing and research company, Genesis Healthcare Co. has completed a third-party equity allocati...
Japan’s Shionogi has announced that the New Drug Application (NDA) for lusutrombopag (S-888711) -an investigationa...
Japan based Sumitomo Dainippon Pharma Co., Ltd. has announced the appointment of Hiroshi Nomura as Representative Direct...
